Literature DB >> 11078815

Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China.

J Y Shao1, H Y Wang, X M Huang, Q S Feng, P Huang, B J Feng, L X Huang, X J Yu, J T Li, L F Hu, I Ernberg, Y X Zeng.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors in Southern China, especially in the Guangdong area. To demonstrate a comprehensive profile of loss of heterozygosity (LOH) in NPC, we applied a large panel of 382 microsatellite polymorphism markers covering all the 22 autosomes in 98 cases of sporadic primary NPC. Of the 335 informative markers, 83 loci showed high level of LOH (presence in equal to or more than 30% cases) and most of the high frequent loci were clustered to chromosome 1p36 and 1p34, 3p14-p21, 3p24-p26, 3q25-q26 and 3q27, 4q31 and 4q35, 5q15-21 and 5q32-q33, 8p22-p23, 9p21-p23 and 9q33-q34, 11p12-p14, 13q14-q13 and 13q31-q32, 14q13-q11, 14q24-q23 and 14q32. High frequency of LOH was found in chromosomes 3, 5, 9 and 11 (>/=50%), while medium frequency of LOH was found in chromosomes 1, 4, 6, 14, 17 and 19 (40-49%). Several new regions showing high frequency of LOH were found in chromosome 1p36, 3q25-q26, 3q27, 5q15-q21, 8p22-p23 and 11p12-14. The relationship between LOH and TNM stage of NPC was evaluated. Regions 6p23 (D6S289), 8p23.1 (D8S549) and 9q34.2 (D9S1826) showed higher frequency of LOH in later stages (III and IV) than in earlier stages (I and II) (P<0.05). Thus, our study provides a global view on allelic loss in the development of NPC and should shed light on the way for localization of putative tumor suppressor genes associated with the pathogenesis of NPC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078815     DOI: 10.3892/ijo.17.6.1267

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  22 in total

1.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

2.  BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.

Authors:  Rekha Rai; Hui Dai; Asha S Multani; Kaiyi Li; Koei Chin; Joe Gray; John P Lahad; Jiyong Liang; Gordon B Mills; Funda Meric-Bernstam; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2006-07-27       Impact factor: 31.743

3.  Identification and characterization of the human NOL7 gene promoter.

Authors:  Tanmayi P Mankame; Guolin Zhou; Mark W Lingen
Journal:  Gene       Date:  2010-03-03       Impact factor: 3.688

4.  MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells.

Authors:  Hong-Ping Zhou; Lu-Xi Qian; Nan Zhang; Jia-Jia Gu; Kai Ding; Jing Wu; Zhi-Wei Lu; Ming-Yu Du; Hong-Ming Zhu; Jian-Zhong Wu; Xia He; Li Yin
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

5.  Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.

Authors:  J Akaishi; M Onda; J Okamoto; S Miyamoto; M Nagahama; K Ito; A Yoshida; K Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

6.  Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Authors:  Guolin Zhou; Colleen L Doçi; Mark W Lingen
Journal:  BMC Cell Biol       Date:  2010-09-27       Impact factor: 4.241

7.  BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.

Authors:  Bo Zhang; Edward Wang; Hui Dai; Ruozhen Hu; Yulong Liang; Kaiyi Li; Guobin Wang; Guang Peng; Shiaw-Yih Lin
Journal:  Carcinogenesis       Date:  2013-06-01       Impact factor: 4.944

8.  TNF-α-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis.

Authors:  Li Xie; Xiao-Nan Liang; Yan Deng; Xue Qin; Shan Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-25       Impact factor: 2.503

9.  Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells.

Authors:  Shu Yang; Shi-Sheng Li; Xin-Ming Yang; Dan-Hui Yin; Lin Wang
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

10.  BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways.

Authors:  Cong Peng; Hua Ying Liu; Ming Zhou; Li Ming Zhang; Xiao Ling Li; Shou Rong Shen; Gui Yuan Li
Journal:  Mol Cell Biochem       Date:  2007-04-26       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.